 |
Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- 12/22/2021
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)-- AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that the deadline for...
12/20/2021FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®Melbourne (Australia) and Indianapolis, IN (U.S.A.) – 20 December 2021. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the...
11/18/2021New offering automates previously manual supply tasks, enabling clinical lab staff to focus on patient careCardinal Health today announced its business, WaveMark™ Supply Management and Workflow Solutions, will now be available for implementation in clinical labs across the U.S. "WaveMark is among the...
11/16/2021Operation will deliver healthcare supplies on-demand to pharmacies, helping mitigate risk of stock-outs and improving accessKannapolis, NC—Nov. 16, 2021 – Cardinal Health (NYSE: CAH) and Zipline, the global leader in instant logistics, today announced a collaboration to offer on-demand autonomous aircraft delivery...
-
11/09/2021- Revenue increased 13% to $44.0 billion
Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings...
-
11/04/2021
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on January 15, 2022 to shareholders of...
10/28/2021Cardinal Health will explore how to better standardize real world evidence for use in regulatory decisionsCardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE) study as part...
10/26/2021Paoli, PA — Cardinal Health Specialty Solutions and Gastrologix, the only gastroenterology (GI)-specific group purchasing organization (GPO) in the United States, working in conjunction with the...
10/14/2021Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD), today...
10/12/2021Cardinal Health (NYSE: CAH) announced today its Strategic Stock Solution now serves nearly 40 hospitals and health systems nationwide, just one year after its launch. In October last year, the...
-
09/28/2021
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an...
-
09/27/2021
Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2022 on November 9 prior to the opening of trading on the New York Stock Exchange. The company will...
09/22/2021DUBLIN, Ohio—Cardinal Health (NYSE: CAH) today launched the Reimbursement Solution—a comprehensive approach designed to help hospitals and health systems minimize their number of claim...
09/20/2021ESG priorities outlined in latest Corporate Citizenship ReportCardinal Health (NYSE: CAH) today announced it has established a goal to reduce Scope 1 and Scope 2 greenhouse gas (GHG) emissions 50% by 2030. "We deliver products and services to improve the...
-
09/04/2021
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that, under the previously announced proposed settlement agreement and process designed to...
08/27/2021IRE ELiT submitted Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA) for the 100 mCi Ge68/Ga68 Galli Eo® generator.DUBLIN, OHIO and FLEURUS, BELGIUM – AUGUST 26, 2021 – Cardinal Health (NYSE: CAH) and IRE ELiT (the radiopharmaceutical subsidiary of IRE Group) are working to expand patient access to novel...
08/23/2021Cardinal Health (NYSE: CAH) announced today a comprehensive talent strategy to increase representation of diverse employees at the manager level and above by 2030. This commitment is specifically...
-
08/20/2021
DUBLIN, OHIO – August 20, 2021 — Cardinal Health (NYSE: CAH) issued a voluntary Medical Device correction notice on June 16, 2021 for Argyle™ UVC Insertion Tray containing Safety Scalpel...
-
08/19/2021
DUBLIN, OHIO – August 19, 2021 — On August 4, 2021, Cardinal Health (NYSE: CAH) initiated a nationwide recall of approximately 267 million MonojectTM Flush Prefilled Saline Syringes (0.9%...
-
08/13/2021
Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 2.616% notes due June 2022 that are outstanding as...
08/12/2021Cardinal Health is pleased to announce an agreement with TerraPower that will help advance the next generation of cancer treatment. Working together, the companies will develop and produce...
-
08/11/2021
Cardinal Health (NYSE: CAH) announced today that it has extended its agreements with CVS Health to distribute pharmaceuticals to retail pharmacies and distribution centers through June 30, 2027....
-
08/05/2021- Revenue increased 16% to $42.6 billion in the fourth quarter
Cardinal Health (NYSE: CAH) today reported that fourth-quarter fiscal 2021 revenue increased 16% to $42.6 billion. This increase includes the favorable prior year comparison from reduced...
08/03/2021Chronicled and Cardinal Health today announced a partnership to leverage a new blockchain-powered solution on the MediLedger Network to streamline operations across the pharmaceutical supply chain...